Fecal Transplantation for Primary Clostridium Difficile Infection
Status:
Recruiting
Trial end date:
2024-01-31
Target enrollment:
Participant gender:
Summary
In this randomized controlled trial the investigators want to compare the effect of one-time
rectal instillation of fecal microbiota transplantation, compared to a ten-day antibiotic
course for the treatment of primary Clostridium difficile infection (CDI). The investigators
hypothetsize that the instillation of feces from a healthy donor will be non-inferior to
vancomycin in inducing a durable cure.
Phase:
Phase 3
Details
Lead Sponsor:
Oslo University Hospital
Collaborators:
Alesund Hospital Diakonhjemmet Hospital Frontier Science & Technology Research Foundation, Inc. Haukeland University Hospital Helse Nord-Trøndelag HF Levanger Hospital Lovisenberg Diakonale Hospital Nordland Hospital Ostfold Hospital Trust Sorlandet Hospital HF South-Eastern Norway Regional Health Authority Sykehuset Telemark The Hospital of Vestfold University Hospital of North Norway University Hospital, Akershus Vestre Viken Hospital Trust